Login / Signup

Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.

Brendan O'KellyPadraig McGettrickDaniel AngelovMichael FayTara McGintyAoife G CotterGerard SheehanJohn S Lambert
Published in: British journal of haematology (2020)
Keyphrases
  • hodgkin lymphoma
  • sars cov
  • case report
  • respiratory syndrome coronavirus
  • advanced non small cell lung cancer
  • coronavirus disease
  • epidermal growth factor receptor